Exercise may help teens and young adults tolerate sarcoma chemo

NCT ID NCT07359911

Recruiting now Symptom relief Sponsor: University of Miami Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a supervised exercise program can help pediatric and young adult sarcoma patients (ages 12-39) tolerate chemotherapy better. Forty newly diagnosed patients will either do weekly exercise sessions or just complete symptom surveys. The main goal is to see if the program is feasible and acceptable, and whether it improves how much chemotherapy they can receive.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: supervised exercise program (resistance and aerobic training)
What this could lead to: If it works, this could show that exercise helps young sarcoma patients stay stronger and complete more of their chemotherapy as planned.
What could go wrong: This is a small, early feasibility study with only 40 participants, so results may not apply to all patients. Exercise may be hard for some to keep up during treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOMA

Contacts and locations

Locations

University of Miami
RECRUITING

Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.